James Davis, Assistant professor and malignant hematology pharmacist at MUSC Hollings Cancer Center, shared an article he and his colleagues authored on X:
“Hot off the press!
Dexamethasone for CRS with teclistamab. You don’t need toci for grade 1 CRS! great team work.”
Authors: James Davis et al.
Rahul Banerjee, Assistant professor at Fred Hutchinson Cancer Center at the University of Washington, reshared the post on X, adding:
“Congrats James Davis et al for great Blood Cancer Journal work!
Consider prescribing “pocket dex” for patients following Multiple Myeloma bsAbs. 10mg for Gr1 CRS after ing with team. Easier for pts, easier for centers, works well, and much cheaper than toci!”